This is especially relevant in rare but well-known patients with genetic predispositions to LV cardiomyopathy, with or without ASD-related mutations (e.g. NKX2.5, GATA4, or TBX5 (ASD-linked), or sarcomeric mutations (non-ASD-linked)). This evidence concerns the gene NKX2-5 and atrial septal defect.